ArticleFuture healthcare journal2022
Hospital at Home: another piece of the armoury against COVID-19.
Article in Future healthcare journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- Supporting older people through Hospital at Home care: a systematic review of patient, carer and healthcare professionals' perspectives.Age and ageing · 2025Pooled it
- Transition of care interventions to manage severe COVID-19 in the ambulatory setting: a systematic review.Internal and emergency medicine · 2024Pooled it
- Communication strategies amongst healthcare professionals, patients and caregivers in Hospital-at-Home Admission Avoidance models for acutely ill older adults: a scoping review.European geriatric medicine · 2026Review
- Experience and Perceptions of Retention Strategies in District Nursing Services: A Web-Based Mixed Methods Cross-Sectional Survey.Journal of advanced nursing · 2026Article
- Acute home-based management initiatives for COVID-19 patients needing oxygen: observational study reporting mortality and hospital admission outcomes.BMC health services research · 2025Observational
- Health Care Providers' Experiences and Perceptions With Telehealth Tools in a Hospital-at-Home Program: Mixed Methods Study.JMIR human factors · 2025Article
- Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security.The Lancet. Global health · 2025Review
- Forecasting readmission in COVID-19 patients utilizing blood biomarkers and machine learning in the Hospital-at-Home program.Frontiers in medicine · 2025Article
- Advancing a virtual home hospital: a blueprint for development and expansion.BMJ open quality · 2024Article
- Citizens' perspectives on relocating care: a scoping review.BMC health services research · 2024Article
- Preference of primary care patients for home-based healthcare and support services: a discrete choice experiment in China.Frontiers in public health · 2024Article
- Home-based initiatives for acute management of COVID-19 patients needing oxygen: differences across The Netherlands.BMC health services research · 2023Article
- Digital health as an enabler for hospital@home: A rising trend or just a vision?Frontiers in public health · 2023Review
- Delivery of elective care in the future.Future healthcare journal · 2022Article
- Making 2022 a learning and reflective year.Future healthcare journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Hospital at Home (@Home) services bring the ward to the patient, providing acute care in the home. The @Home team adapted to support the care of patients with COVID-19 in the community who would otherwise have required hospitalisation. Methods: An evidence-based guideline and treatment bundle (dexamethasone, oxygen, intravenous fluids and thromboprophylaxis) for managing severe COVID-19 was developed. Data were retrospectively extracted from notes of patients with COVID-19 admitted between 16 December 2020 to 14 February 2021, and service users contacted for feedback. Results: One-hundred and twenty-five adults with COVID-19 were treated by @Home; 42 severe (34%) and 83 non-severe (66%) infections; average length of stay was 7 days (interquartile range 4-8). Eight-hundred and seventy-five hospital-occupied bed days were saved. Service users emphasised the importance of being with loved ones and the value of respecting peoples' wishes to be at home. Conclusion: @Home gave people with COVID-19 a choice of active treatment at home, thereby extending available healthcare capacity beyond the acute hospital setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.